8-K/A

0001193125-21-186702.txt : 20210609 0001193125-21-186702.hdr.sgml : 20210609 20210609160336 ACCESSION NUMBER: 0001193125-21-186702 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210415 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043581650 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 211005163 BUSINESS ADDRESS: STREET 1: 30 WINTER STREET CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 857-400-0101 MAIL ADDRESS: STREET 1: 30 WINTER STREET CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: AVEO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20050503 8-K/A 1 d119699d8ka.htm 8-K/A 8-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 15, 2021

AVEO Pharmaceuticals, Inc.

(Exact name of registrant as specified in charter)

Delaware

001-34655

04-3581650

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

30 Winter Street

Boston, Massachusetts

02108

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (857) 400-0101

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.001 par value

AVEO

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)

On April 16, 2021, AVEO Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing that the Board of Directors (the “Board”) of the Company elected Dr. Kevin Cullen as a member of the Board, effective April 15, 2021. Committee assignments for Dr. Cullen were not determined as of filing of the Original Form 8-K.

This Form 8-K/A is being filed to report that on June 9, 2021, the Board appointed Dr. Cullen to its Audit Committee and Compensation Committee, effective immediately.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	AVEO Pharmaceuticals, Inc.

Date: June 9, 2021	By:	/s/ Michael Bailey
		Michael Bailey President and Chief Executive Officer

EX-101.SCH 2 aveo-20210415.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 aveo-20210415_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line1 Entity Address, Address Line One Entity Address City Or Town Entity Address, City or Town Entity Address State Or Province Entity Address, State or Province Entity Address Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre-commencement Tender Offer Pre Commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Security12b Title Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Description Amendment Description Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key EX-101.PRE 4 aveo-20210415_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d119699d8ka_htm.xml IDEA: XBRL DOCUMENT 0001325879 2021-04-15 2021-04-15 true 0001325879 8-K/A 2021-04-15 AVEO Pharmaceuticals, Inc. DE 001-34655 04-3581650 30 Winter Street Boston MA 02108 857 400-0101 false false false false Common Stock, $0.001 par value AVEO NASDAQ false On April 16, 2021, AVEO Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing that the Board of Directors (the “Board”) of the Company elected Dr. Kevin Cullen as a member of the Board, effective April 15, 2021. Committee assignments for Dr. Cullen were not determined as of filing of the Original Form 8-K.This Form 8-K/A is being filed to report that on June 9, 2021, the Board appointed Dr. Cullen to its Audit Committee and Compensation Committee, effective immediately. XML 6 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	Apr. 15, 2021
Cover [Abstract]
Document Type	8-K/A
Document Period End Date	Apr. 15, 2021
Entity Registrant Name	AVEO Pharmaceuticals, Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-34655
Entity Tax Identification Number	04-3581650
Entity Address, Address Line One	30 Winter Street
Entity Address, City or Town	Boston
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02108
City Area Code	857
Local Phone Number	400-0101
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	AVEO
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Amendment Description	On April 16, 2021, AVEO Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing that the Board of Directors (the “Board”) of the Company elected Dr. Kevin Cullen as a member of the Board, effective April 15, 2021. Committee assignments for Dr. Cullen were not determined as of filing of the Original Form 8-K.This Form 8-K/A is being filed to report that on June 9, 2021, the Board appointed Dr. Cullen to its Audit Committee and Compensation Committee, effective immediately.
Amendment Flag	true
Entity Central Index Key	0001325879

EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d119699d8ka.htm aveo-20210415.xsd aveo-20210415_lab.xml aveo-20210415_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d119699d8ka.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d119699d8ka.htm" ] }, "labelLink": { "local": [ "aveo-20210415_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "aveo-20210415_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "aveo-20210415.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "aveo", "nsuri": "http://www.aveooncology.com/20210415", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d119699d8ka.htm", "contextRef": "duration_2021-04-15_to_2021-04-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d119699d8ka.htm", "contextRef": "duration_2021-04-15_to_2021-04-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description", "terseLabel": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.aveooncology.com//20210415/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001193125-21-186702-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-186702-xbrl.zip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end